Majesco Entertainment (NASDAQ:COOL) was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday.
Other analysts have also issued research reports about the stock. Cantor Fitzgerald set a $70.00 price objective on shares of Majesco Entertainment and gave the stock a “buy” rating in a research report on Wednesday, May 9th. ValuEngine raised shares of Majesco Entertainment from a “hold” rating to a “buy” rating in a research report on Wednesday, May 2nd. Finally, Zacks Investment Research raised shares of Majesco Entertainment from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a research report on Tuesday, April 17th.
Shares of COOL stock opened at $28.17 on Wednesday. Majesco Entertainment has a 12 month low of $28.27 and a 12 month high of $29.98.
A number of institutional investors and hedge funds have recently modified their holdings of COOL. Millennium Management LLC acquired a new position in Majesco Entertainment during the fourth quarter worth $3,057,000. Gilder Gagnon Howe & Co. LLC acquired a new position in Majesco Entertainment during the fourth quarter worth $1,507,000. Advisor Group Inc. increased its holdings in shares of Majesco Entertainment by 133.6% in the fourth quarter. Advisor Group Inc. now owns 49,180 shares of the company’s stock valued at $1,141,000 after purchasing an additional 28,130 shares during the last quarter. Ardsley Advisory Partners acquired a new position in shares of Majesco Entertainment in the fourth quarter valued at $327,000. Finally, Wells Fargo & Company MN increased its holdings in shares of Majesco Entertainment by 265.8% in the fourth quarter. Wells Fargo & Company MN now owns 16,825 shares of the company’s stock valued at $391,000 after purchasing an additional 12,225 shares during the last quarter. Institutional investors and hedge funds own 4.72% of the company’s stock.
About Majesco Entertainment
PolarityTE, Inc operates as commercial-stage biotechnology and regenerative biomaterials company in the United States. The company focuses on discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences.
Receive News & Ratings for Majesco Entertainment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Majesco Entertainment and related companies with MarketBeat.com's FREE daily email newsletter.